1. HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies
    Sylwia Bartoszewska et al, 2023, Cancers CrossRef
  2. Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance
    Milad Ashrafizadeh et al, 2024, Cellular and Molecular Life Sciences CrossRef
  3. Circular RNA circ_0005835 promotes promoted neural stem cells proliferation and differentiate to neuron and inhibits inflammatory cytokines levels through miR-576-3p in Alzheimer’s disease
    Xiang Xu et al, 2022, Environmental Science and Pollution Research CrossRef
  4. PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities
    Mohammed Ageeli Hakami et al, 2024, Pathology - Research and Practice CrossRef
  5. CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals
    Alina Catalina Palcau et al, 2022, Molecular Cancer CrossRef
  6. Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (PVT1) in human diseases
    Fang Wu et al, 2023, Genes & Diseases CrossRef
  7. The Emerging Roles of CircPVT1 in Cancer Progression
    Shijie Wu et al, 2025, Current Pharmaceutical Biotechnology CrossRef
  8. miR-3150a-3p, miR-6883-3p and miR-627-5p participate in the phycocyanin-mediated growth diminishment of A549 cells, via regulating a common target toll/interleukin 1 receptor domain-containing adaptor protein
    Shuai Hao et al, 2022, Journal of Functional Foods CrossRef
  9. Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing
    Ji Zhang et al, 2024, Pharmacology & Therapeutics CrossRef
  10. Circular RNAs in lung cancer: implications for preventing therapeutic resistance
    Wenjuan Liu et al, 2024, eBioMedicine CrossRef
  11. lncRNA PVT1: a novel oncogene in multiple cancers
    Ruiming Li et al, 2022, Cellular & Molecular Biology Letters CrossRef
  12. Circ-NUP98 Promotes Lung Adenocarcinoma Development Through Regulating CBX1 by miR-188-3p
    Jie Mei et al, 2024, Biochemical Genetics CrossRef
  13. Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistance
    Wenjuan Liu et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  14. LINC00365 inhibited lung adenocarcinoma progression and glycolysis via sponging miR‐429/KCTD12 axis
    Cheng‐Wei Zhang et al, 2022, Environmental Toxicology CrossRef
  15. Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers: Focus on pathological mechanisms
    Saade Abdalkareem Jasim et al, 2024, Pathology - Research and Practice CrossRef
  16. circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of Bladder Cancer
    Hongyi Zhou et al, 2024, Pharmacogenomics and Personalized Medicine CrossRef
  17. The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
    Tinghao Yan et al, 2022, Frontiers in Oncology CrossRef
  18. Reverse predictive analysis of Rhizoma Pinelliae and Rhizoma Coptidis on differential miRNA target genes in lung adenocarcinoma
    Tianwei Meng et al, 2023, Medicine CrossRef
  19. Exosomal circular RNA: a signature for lung cancer progression
    Bashdar Mahmud Hussen et al, 2022, Cancer Cell International CrossRef
  20. Forkhead box proteins as the critical regulators of cisplatin response in tumor cells
    Amirhosein Maharati et al, 2023, European Journal of Pharmacology CrossRef